Adimab, Inc. — Form D
Adimab, Inc. of Lebanon, NH, a company, filed a Form D exempt-offering notice with the SEC on 2009-10-06. The offering totals $8.2M, of which $8.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-10-06
- Form: D
- Accession: 0001407166-09-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $8.2M
- Amount sold: $8.2M
- Minimum investment: $633
- Investors: 10
- Date of first sale: 2009-09-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-106179
Issuer
- Name: Adimab, Inc.
- CIK: 0001407166
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 16 Cavendish Court, Lebanon, NH, 03766
- Phone: 603-727-7107
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Bill L Maris | Director | Mountain View, CA |
| William J Maris | Director | Cardiff-by-the-Sea, CA |
| Tillman U Gerngross | Director | Waltham, MA |
| Tillman U Gerngross | Executive Officer | Waltham, MA |
| Errik B Anderson | Executive Officer | LEBANON, NH |
| Robert L Birnbaum | Executive Officer | Boston, MA |
| Terrance L McGuire | Director | Waltham, MA |
| Michael L Ross | Director | Boston, MA |
Other filings by this issuer (1)
More